No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Robert W. Gore, Chairman Emeritus of W. L. Gore & Associates, And Inventor of GORE-TEX® Technology Passes at 83

Editor: What To Know

  • Bob Gore, whose scientific discoveries spawned GORE-TEX® Outerwear and paved the way for advancements in industries as varied as performance fabrics, medical devices, space exploration, and filtration, assumed the chairman emeritus role in 2018 after 57 years of service on the Gore board, 30 of those as chairman.
  • Hyatt Award for benefits to society through the use of plastics and the Perkin Medal for innovation in applied chemistry resulting in commercial development from the Society of Chemical Industry (American Section).
  • Today, ePTFE is at the heart of products found everywhere from the depths of space to the inner workings of the human body.

September 18, 2020

Robert W. Gore “Bob”, chairman emeritus of the board of directors of  W. L. Gore & Associates, a global material science company dedicated to improving lives through advancements in technology, passed away on September 17 at the age of 83.

Bob Gore, whose scientific discoveries spawned GORE-TEX® Outerwear and paved the way for advancements in industries as varied as performance fabrics, medical devices, space exploration, and filtration, assumed the chairman emeritus role in 2018 after 57 years of service on the Gore board, 30 of those as chairman. Bob also served as president of Gore from 1976 to 2000.

During his tenure as president, Gore became a billion-dollar enterprise. Marking the occasion in 1996, Bob said, “We plan to leave a legacy to society and to future generations: infants with surgically reconstructed hearts that live because of our medical products; governments of free societies that are better able to protect themselves because of defense products; communities with cleaner and healthier environments because of our filtration and sealant products; And yes, people that just have more fun in the outdoors because of our GORE-TEX® Outerwear.”

Bob’s commitment to research and development led to his 1969 discovery of a versatile new polymer form, expanded polytetrafluoroethylene (ePTFE). The introduction of this groundbreaking new material opened a world of possibilities for products and further innovations. The substance provided myriad new product applications including GORE-TEX® Fabrics, the world’s first waterproof-breathable outerwear, and a product that through the years has become synonymous with the outdoors.

Bob’s ePTFE innovation came about at a period in the late 1960s when the big research challenge for Gore was to develop products for computing, space exploration and defense. Trends in electronics at that time made it clear that miniature integrated circuits were the wave of the future and that less cable would be needed as computers became smaller.

One night in October 1969, Bob was researching a new process for stretching extruded PTFE into pipe-thread tape when he discovered that the polymer could be “expanded.” The discovery followed a series of unsuccessful experiments in which he was attempting to stretch heated rods of PTFE by about 10 percent.

As it turned out, the right conditions for stretching PTFE were counterintuitive. Instead of slowly stretching the heated material, he applied a sudden, accelerating yank that unexpectedly caused it to expand to nearly 1000 percent. This resulted in the transformation of solid PTFE into a microporous structure that was mostly air.

Continued advancement in the technology and application of ePTFE enabled Gore to deliver groundbreaking solutions to a wide array of industries. Today, ePTFE is at the heart of products found everywhere from the depths of space to the inner workings of the human body. Along the way, Bob would be awarded nine patents for his work with fluoropolymers. He was elected to the National Academy of Engineering for his technical achievements and in 2006 was inducted into the National Inventors Hall of Fame.

Through his long career, he received many additional honors, including the Society of Plastics Engineers John W. Hyatt Award for benefits to society through the use of plastics and the Perkin Medal for innovation in applied chemistry resulting in commercial development from the Society of Chemical Industry (American Section). Bob also was an active member of the American Chemical Society and the 2019 Carothers Award recipient (Delaware Section).

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy